3183 logo

WIN-Partners Co., Ltd. Stock Price

TSE:3183 Community·JP¥35.4b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

3183 Share Price Performance

JP¥1,289.00
-61.00 (-4.52%)
JP¥1,289.00
-61.00 (-4.52%)
Price JP¥1,289.00

3183 Community Narratives

There are no narratives available yet.

Trending Discussion

No trending discussion available.

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Flawless balance sheet 6 star dividend payer.

0 Risks
2 Rewards

WIN-Partners Co., Ltd. Key Details

JP¥92.3b

Revenue

JP¥81.5b

Cost of Revenue

JP¥10.7b

Gross Profit

JP¥8.7b

Other Expenses

JP¥2.0b

Earnings

Last Reported Earnings
Jun 30, 2026
Next Reporting Earnings
n/a
74.18
11.63%
2.21%
0%
View Full Analysis

About 3183

Founded
1983
Employees
653
CEO
Hideumi Akizawa
WebsiteView website
www.win-partners.co.jp

WIN-Partners Co., Ltd., through its subsidiaries, distributes medical devices to medical institutions primarily in Japan. The company offers percutaneous coronary intervention products, including PTCA balloon catheters, drug-eluting stents, and intravascular ultrasound catheters; pacemakers, implantable cardioverter defibrillators, cardiac resynchronization therapy defibrillators, and ablation catheters; and stent grafts, transcatheter heart valves, and mechanical heart valves. It also provides peripheral vascular stents, carotid artery stents, and embolic coils; and insulin pumps, as well as continuous glucose monitoring, and computed tomography equipment. WIN-Partners Co., Ltd. was founded in 1983 and is headquartered in Tokyo, Japan.

Recent 3183 News & Updates

Recent updates

No updates